An Expert Interview With Dr. Philip Seeman, MD, PhD
Philip Seeman, MD, PhD, made the breakthrough discovery of the D2 receptor, a target for all antipsychotics. In this interview with Medscape's Jessica Gould, Dr. Seeman, Professor Emeritus, University of Toronto, explains the significance of this finding and three other advances he and his colleagues made that have contributed to our knowledge of dopamine.
Diagram courtesy of CNSforum by The Lundbeck Institute
No comments:
Post a Comment